ArticleBlood cancer discovery2021

Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors.

Ahmad S Alotaibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.